Publications by authors named "Louis Meyblum"

Objectives: Renal transplant biopsy remains the gold standard for etiological diagnosis of graft dysfunction and subsequent management. When percutaneous renal biopsy (PRB) is contraindicated due to bleeding risk or limited percutaneous access, the fluoroscopy-guided transvenous femoral renal transplant biopsy (TFRB) might be a valuable alternative. This study aims to describe the TFRB technique, its safety, and efficacy.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the link between portal hypertension (PHT) complications and the use of non-selective beta blockers (NSBBs) in patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE).
  • Of the 109 patients analyzed, 32% either did not receive NSBBs despite needing them, increasing the risk of complications like ascites and hepatic encephalopathy, especially in those with esophageal varices (EV).
  • The findings highlight that inadequate NSBB treatment significantly correlates with higher rates of PHT-related complications and hindered access to further HCC treatments, suggesting a need for better screening and prophylactic measures in patients undergoing TACE.
View Article and Find Full Text PDF

Objectives: Approximately 40% of patients with colorectal cancer will develop liver metastases. Hepatic arterial infusion chemotherapy (HAIC) represents a valuable treatment option, with curative, palliative, or adjuvant intent. The aim of our study was to describe technical considerations, safety, and oncological outcomes of patients receiving HAIC.

View Article and Find Full Text PDF

Background: The definition of Takayasu arteritis (TAK) remission and disease activity is still unclear. Vascular imaging is an essential tool for following-up patients. Herein, we aimed to compare the evolution of vascular lesions (i.

View Article and Find Full Text PDF

Background: Despite the promising efficacy of immune checkpoint blockers (ICB), tumor resistance and immune-related adverse events hinder their success in cancer treatment. To address these challenges, intratumoral delivery of immunotherapies has emerged as a potential solution, aiming to mitigate side effects through reduced systemic exposure while increasing effectiveness by enhancing local bioavailability. However, a comprehensive understanding of the local and systemic distribution of ICBs following intratumoral administration, as well as their impact on distant tumors, remains crucial for optimizing their therapeutic potential.

View Article and Find Full Text PDF

Purpose: The purpose of this study was to analyze the intrahepatic perfusion redistribution after embolization of hepatic arterial variants during percutaneous arterial port catheter placement as well as to investigate the treatment efficacy of intraarterial chemotherapy in perfusion redistribution-dependent compared to redistribution-independent liver areas.

Materials And Methods: This retrospective study included 62 patients (67.7% males, mean age of 56 ± 12 years).

View Article and Find Full Text PDF

Background: Embolization of the middle meningeal artery (MMA) has emerged as a potential treatment of chronic subdural hematomas (CSDHs).

Objective: To evaluate the impact on recurrence rate of postsurgical embolization of CSDH in patients with a higher than average risk of recurrence.

Methods: A monocentric retrospective study was performed on retrospectively collected data.

View Article and Find Full Text PDF

Objectives: Vertebral augmentation (VA) has become routinely used in vertebral compression fractures (VCFs). VCFs are often associated with posterior wall protrusions (PWPs), which theoretically contraindicates vertebroplasty due to a higher risk of neurological complications. The latest generation of VA devices uses intravertebral cranio-caudal expandable implants to improve the correction of structural deformities but could also be used to prevent further PWP during cement injection.

View Article and Find Full Text PDF